Secondary Analyses
Below is a summary of completed, in progress, and planned secondary analyses for the VICTORIA study.
Analyses | Status (Completed, In Progress, Planned) | Related Links |
---|---|---|
Contextual with other trials | Completed | Circulation publication |
Impact of natriuretic peptides on result and their evolution | Completed | JACC FF publication HFA 20 presentation |
Index admission groups | Completed | JAMA Cardiol. publication |
Prognostic model | In Progress | HFA 21 Presentation |
Standard of Care | In Progress | HFSA 2020 presentation |
Anemia | In Progress | |
Baseline changes in renal function | In Progress | Eur J Heart Fail. publication |
Sequential natriuretic peptides and outcomes | In Progress | HFA 21 Presentation |
Atrial fibrillation | In Progress | HFA 21 Presentation |
Safety/hypotension/syncope/ BP response | In Progress | HFA 21 Presentation |
CAD/non CAD | In Progress | ACC 21 presentation |
Sacubitril/valsartan baseline/ drop ins | In Progress | |
Recurrent events | In Progress | |
ECHO 1 paired data and Rx effect | In Progress | HFA 20 presentation |
Genomics | In Progress | |
Biomarkers | In Progress | ACC 21 presentation |
Health economics | In Progress | |
NA registry | In Progress | HFSA 20 Presentation |
NA Registry – GDMT | In Progress | HFSA 20 Presentation |
PK/PD and PK adherence | In Progress | |
QoL as an outcome/predictor | In Progress | |
LVEF stratification | In Progress | |
Sex/Age | In Progress | |
Geographic variation | In Progress | |
Expanded endpoints | In Progress | |
Risk Scores across spectrum MAGGIC, SHFM, others | Planned | |
ECHO 2 remodelling | Planned |
